Kirsty J. Shaw
Microsystems for personalized biomolecular diagnostics
Shaw, Kirsty J.; Birch, Christopher; Hughes, Elizabeth M.; Jakes, Adam D.; Greenman, John; Haswell, Stephen J.
Elizabeth M. Hughes
Adam D. Jakes
Professor John Greenman J.Greenman@hull.ac.uk
Professor of Tumour Immunology
Stephen J. Haswell
The development of microfluidic methodology that can be used in conjunction with drug screening and biomolecular diagnostics offers a route to evidence-based personalized medical care. Ideally, all personal diagnostics are best carried out in a rapid and frequent manner and a microfluidic interface can provide appropriate methodology. The ability to perform genetic analysis or biomarker detection at point-of-care would allow the clinician to decide on the most informed course of treatment. Microfluidic systems for biomolecular analysis at all levels, from genes to whole tissue biopsies, have been proposed. Much of the work presented here is at an early stage of development but will consider the range of design considerations together with the plethora of potential applications of integrated microfluidic technology.
|Journal Article Type||Article|
|Journal||ENGINEERING IN LIFE SCIENCES|
|Peer Reviewed||Peer Reviewed|
|APA6 Citation||Shaw, K. J., Birch, C., Hughes, E. M., Jakes, A. D., Greenman, J., & Haswell, S. J. (2011). Microsystems for personalized biomolecular diagnostics. Engineering in Life Sciences, 11(2), 121-132. doi:10.1002/elsc.201000175|
|Keywords||Diagnostics; Healthcare; Integration; Microfluidics; Personalized medicine|
You might also like
The effect of radioiodine treatment on the diseased thyroid gland